Concentrix price target lowered to $80 from $100 at Canaccord

Canaccord analyst Joseph Vafi lowered the firm’s price target on Concentrix (CNXC) to $80 from $100 and keeps a Buy rating on the shares. The firm said while the macro remains a legitimate headwind across the company’s end markets, they also believe that if AI were going to emerge as a true disruptor here, they would have seen some early signs by now.